Advanced Medical Solutions GroupCHIX:AMSL +0.18%93 ROC (Joel Greenblatt) % is 17.91% as of Dec. 2025, which is 59% below its 10-year median of 44.10. GuruFocus rates CHIX:AMSL with a GF Score™ of 93/100 and a GF Value™ of £3.69 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 841 Medical Devices & Instruments companies, Advanced Medical Solutions Group ranks better than 68.25% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Advanced Medical Solutions Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 17.91%.
The historical rank and industry rank for Advanced Medical Solutions Group's ROC (Joel Greenblatt) % or its related term are showing as below:
CHIX:AMSl'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 14.31 Med: 44.1 Max: 82.28
Current: 18.23
During the past 13 years, Advanced Medical Solutions Group's highest ROC (Joel Greenblatt) % was 82.28%. The lowest was 14.31%. And the median was 44.10%.
CHIX:AMSl's ROC (Joel Greenblatt) % is ranked better than 68.25% of 841
companies
in the Medical Devices & Instruments industry
Industry Median: 3.94
vs CHIX:AMSl: 18.23
Advanced Medical Solutions Group (CHIX:AMSl) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Medical Solutions Group ROC (Joel Greenblatt) % Chart
CHIX:AMSL vs ISRG, BDX, MDLN: ROC (Joel Greenblatt) % Comparison
For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Medical Solutions Group ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Advanced Medical Solutions Group's ROC (Joel Greenblatt) % falls into.
Advanced Medical Solutions Group ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 17.91% mean?
Advanced Medical Solutions Group (CHIX:AMSL) has a ROC (Joel Greenblatt) % of 17.91% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Advanced Medical Solutions Group and its competitors. This is 59% below median its historical median of 44.10. Over the past decade, Advanced Medical Solutions Group's ROC (Joel Greenblatt) % has ranged from 14.31 to 82.28. According to the industry distribution chart, Advanced Medical Solutions Group ranks #267 out of 841 companies in the Medical Devices & Instruments industry, placing it in the top 31.7%.
Is Advanced Medical Solutions Group's ROC (Joel Greenblatt) % too high?
Advanced Medical Solutions Group's current ROC (Joel Greenblatt) % of 17.91% is 59% below median its 10-year median of 44.10. Over the past 10 years, this metric has ranged from a low of 14.31 to a high of 82.28. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 3.94. Advanced Medical Solutions Group's value of 17.91% is 354.6% above this industry median. Based on the distribution chart, Advanced Medical Solutions Group ranks #267 out of 841 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Advanced Medical Solutions Group has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's ROC (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Advanced Medical Solutions Group ranks #267 out of 841 companies for ROC (Joel Greenblatt) %. This puts Advanced Medical Solutions Group in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 3.94. Advanced Medical Solutions Group's value of 17.91% is 354.6% above this benchmark. Historically, Advanced Medical Solutions Group's own ROC (Joel Greenblatt) % has ranged from 14.31 to 82.28 over the past decade. While the company's 10-year median is 44.10 vs. the industry median of 3.94, Advanced Medical Solutions Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 3.94, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Medical Solutions Group's current ROC (Joel Greenblatt) % of 17.91% is 354.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Advanced Medical Solutions Group and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 3.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Medical Solutions Group's current ROC (Joel Greenblatt) % is 17.91%, which is 59% below median its own 10-year median of 44.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (CHIX:AMSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.69, compared to a current price of £2.81 — trading 23.8% below its estimated fair value. The current ROC (Joel Greenblatt) % is 17.91%, which is 59% below median its 10-year median of 44.10 and 354.6% above the Medical Devices & Instruments industry median of 3.94. Advanced Medical Solutions Group's overall GF Score™ is 93/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Advanced Medical Solutions Group (CHIX:AMSL), the current ROC (Joel Greenblatt) % is 17.91% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Medical Solutions Group (CHIX:AMSL) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued.
The current stock price of £2.81 is trading 23.8% below its estimated GF Value™ of £3.69.
GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.
Key valuation signals for CHIX:AMSL:
ROC (Joel Greenblatt) %: 17.91% (59% below median its 10-year median of 44.10)
GF Value™: £3.69 vs. price of £2.81 (23.8% below fair value)
Industry Position: 354.6% above the Medical Devices & Instruments median (#267 of 841)
No single metric tells the full story. See the CHIX:AMSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Medical Solutions Group Business Description
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
93GF Score
Get the complete analysis for CHIX:AMSL
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMSL has been successfully added to your 
